Headlands Technologies’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-7,261
Closed -$859K 1177
2024
Q4
$859K Buy
7,261
+3,219
+80% +$376K 0.09% 242
2024
Q3
$447K Buy
4,042
+3,962
+4,953% +$414K 0.05% 363
2024
Q2
$7.87K Buy
80
+56
+233% +$5.71K ﹤0.01% 985
2024
Q1
$2.69K Sell
24
-1,764
-99% -$190K ﹤0.01% 1147
2023
Q4
$180K Buy
1,788
+1,249
+232% +$124K 0.05% 292
2023
Q3
$46.8K Buy
+539
New +$48.7K 0.02% 458
2023
Q2
Sell
-526
Closed -$39.7K 796
2023
Q1
$39.7K Sell
526
-368
-41% -$27.8K 0.03% 247
2022
Q4
$69K Buy
+894
New +$67.9K 0.05% 244

Other funds holding CAH

Headlands Technologies's CAH Position: Q1 2025 in Review

Headlands Technologies sold out of Cardinal Health (CAH) in Q1 2025, closing a stake of 7,261 shares — an estimated $859K sold.

Headlands Technologies first reported a position in CAH in Q4 2022 and held it in 8 quarters. The position peaked at $859K in Q4 2024. 1,148 funds tracked by Wall St. Rank hold CAH as of Q1 2025.

  • Headlands Technologies reported no remaining Cardinal Health position as of Q1 2025 after selling out during the quarter.
  • Headlands Technologies sold 7,261 Cardinal Health shares in Q1 2025, an estimated $859K.
  • Headlands Technologies first reported a position in Cardinal Health in Q4 2022 and held it in 8 quarters.
  • Headlands Technologies's Cardinal Health position peaked at $859K in Q4 2024.
  • 1,148 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2025.

Based on Headlands Technologies's 13F filing for Q1 2025, filed 9 May 2025.